Unique substance warnings: Difference between revisions
>David Hedlund |
>David Hedlund https://go.drugbank.com/drugs/DB00557 |
||
Line 17: | Line 17: | ||
===[[Routes of administration]]=== | ===[[Routes of administration]]=== | ||
* [[Codeine]]: Intravenous codeine can result in nonimmune mast-cell degranulation and resulting anaphylactoid reaction. | * [[Codeine]]: Intravenous codeine can result in nonimmune mast-cell degranulation and resulting anaphylactoid reaction. | ||
* [[Hydroxyzine]]: Intravenous | * [[Hydroxyzine]]: Intravenous forms are not available because they pose a risk of causing hemolysis.<ref>https://go.drugbank.com/drugs/DB00557</ref> | ||
* [[Ketamine]]: Ketamine taken intravenously quicker than 1.5 minute can cause breathing depression for short time (up to a minute). - Ketamine: Dreams and Realities, p276 | * [[Ketamine]]: Ketamine taken intravenously quicker than 1.5 minute can cause breathing depression for short time (up to a minute). - Ketamine: Dreams and Realities, p276 | ||